Omar Ali

Advisor on value Based Pricing, US Embassy, Lecturer Value Based Pricing & Outcomes Based Innovative Contracting, University of Portsmouth & Former Member Adoption & Impact Panel, NICE
University of Portsmouth
Biosimilars Commercialisation Summit Agenda 2019

Biosimilars Commercialisation Summit Agenda 2019

View Content

Conference Day Two

Thursday, March 5th, 2020

12:00 PM Payer Perspectives on Value Drivers for Biosimilars

  • Undertake a Healthcare Fiscal overview, exploring the medicine funding landscape for biosimilars and the New NHS CQUINS on Biosimilars and its implementation  
  • Hear how payers are aligning biosimilars with innovative parent brands to streamline patient care settings
  • Consider what the differential payer value drivers are for switching from parent brand to biosimilar, compared to biosimilar to biosimilar
  • Bridge the uncertainty gap between payers &pharma – the shifting paradigm

1:40 PM Value Based Agreements with Biosimilars

  • Gain a comprehensive knowledge of what a value based agreement is and its significance to the biosimilars industry
  • Learn how to construct your own value based agreement
  • Explore both market access and payer perspectives on risk sharing

3:25 PM Panel Discussion: The Market Value of Real World Evidence in the Education of Stakeholders

  • Explore the contentious idea that real world evidence is an unnecessary undertaking in the commercialisation of biosimilars
  • Consider the pros and cons of incremental registration for multiple indications
  • Hear the views of a sponsoring company, pharmacist, and payer

Check out the incredible speaker line-up to see who will be joining Omar.

Download The Latest Agenda